カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

ヒト化マウス＆ラットモデルの世界市場予測（～2027）：種類別、用途別、エンドユーザー別、地域別

◆英語タイトル：Humanized Mouse and Rat Model Market by Type (Genetic, Cell-Based (CD34, PBMC, BLT)), Application (Neuroscience, Oncology, Toxicology, Immunology & Infectious diseases, Hematopoiesis), End Users, and Region - Global Forecast to 2027
	◆商品コード：BT4938-23 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2023年5月8日 ◆ページ数：180 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：バイオ

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥742,500	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥997,500	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,222,500	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

マーケッツアンドマーケッツ社では、世界のヒト化マウス＆ラットモデル市場規模が2022年237百万ドルから2027年には338百万ドルに達し、予測期間中（2022年から2027年まで）の年平均成長率は7.4%と予測しています。当調査資料では、ヒト化マウス＆ラットモデルの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（ヒト化マウスモデル、ヒト化ラットモデル）分析、用途別（腫瘍、免疫＆感染症、神経科、造血、その他）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、受託研究機関、学術＆研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況、隣接/関連市場などの項目を掲載しています。なお、当書に掲載されている企業情報には、Charles River Laboratories International, Inc. (US)、The Jackson Laboratory (JAX) (US)、Taconic Biosciences, Inc. (US)、Crown Bioscience (US)、Envigo (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のヒト化マウス＆ラットモデル市場規模：種類別
　 - ヒト化マウスモデルの市場規模
　 - ヒト化ラットモデルの市場規模
・世界のヒト化マウス＆ラットモデル市場規模：用途別
　 - 腫瘍における市場規模
　 - 免疫＆感染症における市場規模
　 - 神経科における市場規模
　 - 造血における市場規模
　 - その他用途における市場規模
・世界のヒト化マウス＆ラットモデル市場規模：エンドユーザー別
　 - 製薬＆バイオテクノロジー企業における市場規模
　 - 受託研究機関における市場規模
　 - 学術＆研究機関における市場規模
・世界のヒト化マウス＆ラットモデル市場規模：地域別
　 - 北米のヒト化マウス＆ラットモデル市場規模
　 - ヨーロッパのヒト化マウス＆ラットモデル市場規模
　 - アジア太平洋のヒト化マウス＆ラットモデル市場規模
　 - 中南米のヒト化マウス＆ラットモデル市場規模
　 - 中東/アフリカのヒト化マウス＆ラットモデル市場規模
・競争状況
・企業情報

“世界のヒト化マウス＆ラットモデル市場は、2022年の2億3,700万米ドルから2027年には3億3,800万米ドルに達し、2022年から2027年の予測期間中の年平均成長率は7.4％と予測”
現在、機能的なヒト細胞、遺伝子、組織を移植した免疫不全マウスは、ヒト疾患の前臨床研究の重要なツールとして浮上しています。ヒト化マウスは、遺伝的、生物学的、行動学的特徴がヒトに似ているため、医療試験が行われます。また、ヒトのいくつかの病状はヒト化モデルで再現できるため、市場の成長を促進しています。このようなヒト化マウス＆ラットモデル市場の成長とともに、個別化医療に対する需要の高まり、政府や民間からの投資や助成金による支援の拡大、製薬企業やバイオテクノロジー企業による研究開発活動の増加が、市場の成長を後押ししています。

“ヒト化ラットモデル市場はタイプ別セグメントで第2位のシェアを占める見込み”
タイプ別では、ヒト化マウス＆ラットモデル市場はヒト化マウスモデルとヒト化ラットモデルに区分されます。2021年には、ヒト化ラットモデル市場が第2位のシェアを占めました。ラットの肝臓代謝（肝酵素の数や種類）はヒトと類似しています。また、ラットの外科的改造やサンプルの採取も容易です。ラットモデルのその他の利点としては、吸収が良好であること、取り扱いが容易であること、より強力な静脈内投与に耐えられること、組織サンプルがより大きいことなどが挙げられます。マウスモデルに対するラットモデルのこれらの利点は、ヒト化ラットモデルの開発を後押ししています。

“ヒト化マウス＆ラットモデル市場の用途別セグメントでは、がん領域が最も高い市場シェアを占める”
用途別に見ると、ヒト化マウス＆ラットモデル市場は、腫瘍学、免疫学・感染症、神経科学、造血、毒物学、その他の用途に区分されます。ヒト化マウスモデルは、遺伝子機能の検証、新規がん遺伝子と腫瘍バイオマーカーの同定、腫瘍形成の根底にある分子・細胞メカニズムの理解、新規治療戦略を検証するためのより良い臨床モデルの提供に有用であるためです。

“欧州はヒト化マウス＆ラットモデル市場で2番目に大きな地域”
ヒト化マウス＆ラットモデル市場は、北米、欧州、アジア太平洋地域、中南米（LATAM）、中東・アフリカ（MEA）に区分されます。北米に次いで、欧州では、医薬研究開発費の増加と製薬およびバイオテクノロジーの成長が高い市場シェアの主要な要因となっています。

本レポートのために実施した一次インタビューは以下のように分類されます：
– 回答者別供給側80%、需要側20%
– 役職別管理職：55%、CXOおよびディレクタークラス：20%、経営幹部：25%
– 地域別北米45％、欧州30％、アジア太平洋地域20％、中南米3％、中東・アフリカ2%

ヒト化マウス＆ラットモデル市場の主要企業は、Charles River Laboratories International, Inc.（米国）、The Jackson Laboratory (JAX)（米国）、Taconic Biosciences, Inc.（米国）、Crown Bioscience（米国）、Envigo（米国）。

調査範囲
本レポートは、ヒト化マウス＆ラットモデル市場の詳細な情報を提供します。種類、用途、エンドユーザー、地域などの異なるセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの企業プロフィールや最近の動向、主要な市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、ヒト化マウス＆ラットモデル市場全体とそのサブセグメントについて、概算収益の近似値を提供することで、市場リーダーや新規参入者を支援します。また、ステークホルダーが競合状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートにより、関係者は市場動向を理解し、主要な市場促進要因、阻害要因、課題、動向、機会に関する情報を得ることができます。

本レポートは、以下のポイントに関する洞察を提供します：
– ヒト化マウス＆ラットモデル市場の成長に影響を与える、主要推進要因（ヒト化モデルを使用した研究活動の増加、個別化医療に対する需要の高まり、がん研究に対する政府および民間部門からの継続的な支援とイニシアチブ、製薬・バイオテクノロジー分野の研究開発の成長）、阻害要因（カスタムヒト化モデルの高コスト、研究における動物モデルの倫理的使用に関する法規制）、機会（ヒト化PDXモデルの需要増加、生物医学研究における強力なツールとしてのCRISPRの出現、ヒト化ラットモデルの需要増加）、課題（動物実験の代替、ヒト化マウスモデルの限界）分析。
– 製品開発/イノベーション：新しく発売された製品に関する詳細な洞察、ヒト化マウス＆ラットモデル市場の技術評価。
– 市場開発：有利な市場に関する包括的情報 – 当レポートでは、さまざまな地域のヒト化マウス＆ラットモデル市場を分析。
– 市場の多様化：新製品、未開拓の地域、最近の開発、ヒト化マウス＆ラットモデル市場への投資に関する詳細な情報
– 競合評価： Charles River Laboratories International, Inc.（米国）、The Jackson Laboratory (JAX)（米国）、Taconic Biosciences, Inc.（米国）、Envigo（米国）など、ヒト化マウス＆ラットモデル市場における主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。また、本レポートは、関係者がヒト化マウス＆ラットモデル市場の動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供。

❖ レポートの目次 ❖

1 INTRODUCTION 20
1.1 STUDY OBJECTIVES 20
1.2 MARKET DEFINITION 20
1.2.1 INCLUSIONS AND EXCLUSIONS 21
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED 22
1.4 CURRENCY CONSIDERED 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 23
1.7 SUMMARY OF CHANGES 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
2.1.1 SECONDARY DATA 24
2.1.2 PRIMARY DATA 24
2.1.2.1 Breakdown of primary sources 25
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25
2.1.2.2 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 26
FIGURE 2 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 26
FIGURE 3 CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 27
FIGURE 4 HUMANIZED MOUSE AND RAT MODEL MARKET: FINAL CAGR PROJECTIONS 28
FIGURE 5 HUMANIZED MOUSE AND RAT MODEL MARKET: SEGMENTAL ASSESSMENT 28
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
FIGURE 6 DATA TRIANGULATION METHODOLOGY 30
2.4 MARKET RANKING ANALYSIS 30
2.5 RESEARCH ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
FIGURE 7 HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 32
FIGURE 8 HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 33
FIGURE 9 HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 34
FIGURE 10 REGIONAL SNAPSHOT OF HUMANIZED MOUSE AND RAT MODEL MARKET 35
4 PREMIUM INSIGHTS 36
4.1 HUMANIZED MOUSE AND RAT MODEL MARKET OVERVIEW 36
FIGURE 11 GROWING RESEARCH ACTIVITIES USING HUMANIZED MODELS TO DRIVE MARKET GROWTH 36
4.2 ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER AND COUNTRY (2021) 37
FIGURE 12 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED ASIA PACIFIC MARKET IN 2021 37
4.3 GEOGRAPHICAL SNAPSHOT OF HUMANIZED MOUSE AND RAT MODEL MARKET 38
FIGURE 13 INDIA TO WITNESS HIGHEST GROWTH RATE FROM 2022 TO 2027 38
4.4 HUMANIZED MOUSE AND RAT MODEL MARKET, BY REGION 38
FIGURE 14 NORTH AMERICA TO DOMINATE MARKET IN 2027 38
4.5 HUMANIZED MOUSE AND RAT MODEL MARKET: DEVELOPED VS. DEVELOPING MARKETS 39
FIGURE 15 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
FIGURE 16 HUMANIZED MOUSE AND RAT MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
5.2.1 DRIVERS 41
5.2.1.1 Increasing research activities using humanized models 41
5.2.1.2 Rising demand for personalized medicine 41
5.2.1.3 Continuous support and initiatives from government and private sectors for cancer research 42
5.2.1.4 Growing R&D activities in pharmaceutical and biotechnology sectors 42
TABLE 1 NUMBER OF DRUGS IN DEVELOPMENT, BY DISEASE AREA (2020) 43
5.2.2 RESTRAINTS 43
5.2.2.1 High cost of custom humanized models 43
5.2.2.2 Laws and regulations for ethical use of animal models in research 43
5.2.3 OPPORTUNITIES 44
5.2.3.1 Rising demand for humanized PDX models 44
5.2.3.2 Emergence of CRISPR as a powerful tool in biomedical research 44
5.2.3.3 Rising demand for humanized rat models 45
5.2.4 CHALLENGES 45
5.2.4.1 Alternatives for animal testing 45
5.2.4.2 Limitations of humanized mouse models 46
5.3 REGULATORY ANALYSIS 46
5.3.1 NORTH AMERICA 46
5.3.2 EUROPE 47
5.3.3 ASIA PACIFIC 49
5.3.3.1 China 49
5.3.3.2 Japan 49
5.3.3.3 India 50
5.3.3.4 Australia 50
5.3.4 LATIN AMERICA 50
5.3.5 MIDDLE EAST & AFRICA 51
5.4 PRICING ANALYSIS 51
TABLE 2 PRICE OF HUMANIZED MOUSE MODELS (2022) 51
5.5 TECHNOLOGY ANALYSIS 51
5.6 VALUE CHAIN ANALYSIS 52
FIGURE 17 CREATION OF HUMANIZED MODELS—MAXIMUM VALUE IS ADDED DURING IMPLANTATION OF GRAFT/TUMOR CELLS IN IMMUNODEFICIENT MICE OR RATS 52
5.7 ECOSYSTEM ANALYSIS OF HUMANIZED MOUSE AND RAT MODEL MARKET 53
FIGURE 18 ECOSYSTEM ANALYSIS OF HUMANIZED MOUSE AND RAT MODEL MARKET 53
TABLE 3 SUPPLY CHAIN ECOSYSTEM 54
5.8 PORTER’S FIVE FORCES ANALYSIS 55
TABLE 4 HUMANIZED MOUSE AND RAT MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS 55
5.8.1 THREAT OF NEW ENTRANTS 55
5.8.2 THREAT OF SUBSTITUTES 55
5.8.3 BARGAINING POWER OF BUYERS 55
5.8.4 BARGAINING POWER OF SUPPLIERS 55
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 55
5.9 PATENT ANALYSIS 56
FIGURE 19 PATENT APPLICATIONS FOR HUMANIZED MOUSE MODEL MARKET, JANUARY 2013 –SEPTEMBER 2022 56
6 HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE 57
6.1 INTRODUCTION 58
TABLE 5 HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 58
6.2 HUMANIZED MOUSE MODELS 58
TABLE 6 HUMANIZED MOUSE MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 59
TABLE 7 HUMANIZED MOUSE MODEL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59
6.2.1 GENETIC HUMANIZED MOUSE MODELS 60
6.2.1.1 Genetic humanized mouse models segment to account for larger market share 60
TABLE 8 GENETIC HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 60
6.2.2 CELL-BASED HUMANIZED MOUSE MODELS 61
TABLE 9 CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 61
TABLE 10 CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 61
6.2.2.1 CD34 humanized mouse models 62
6.2.2.1.1 Increasing demand for stem cell therapy to drive market growth 62
TABLE 11 CD34 HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63
6.2.2.2 PBMC humanized mouse models 63
6.2.2.2.1 Growing prevalence of infectious diseases to drive demand 63
TABLE 12 PBMC HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 64
6.2.2.3 BLT humanized mouse models 65
6.2.2.3.1 Increasing HIV cases to drive demand 65
TABLE 13 BLT HUMANIZED MOUSE MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 66
6.3 HUMANIZED RAT MODELS 66
6.3.1 LACK OF GERMLINE-COMPETENT RAT EMBRYONIC STEM CELL LINES AFFECTED ADOPTION OVER LAST TWO DECADES 66
TABLE 14 HUMANIZED RAT MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67
7 HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION 68
7.1 INTRODUCTION 69
TABLE 15 HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 69
7.2 ONCOLOGY 70
7.2.1 INCREASING APPLICATIONS OF MOUSE MODELS IN CANCER STUDIES TO DRIVE GROWTH 70
TABLE 16 HUMANIZED MOUSE AND RAT MODEL MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 71
7.3 IMMUNOLOGY AND INFECTIOUS DISEASES 71
7.3.1 DEVELOPMENT OF ADVANCED MODELS FOR HUMAN IMMUNOLOGY STUDIES TO BOOST GROWTH 71
TABLE 17 HUMANIZED MOUSE AND RAT MODEL MARKET FOR IMMUNOLOGY AND INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION) 72
7.4 NEUROSCIENCE 73
7.4.1 INCREASING FOCUS ON HUMANIZED MOUSE MODEL DEVELOPMENT FOR CNS DISORDERS TO PROPEL GROWTH 73
TABLE 18 HUMANIZED MOUSE AND RAT MODEL MARKET FOR NEUROSCIENCE, BY COUNTRY, 2020–2027 (USD MILLION) 73
7.5 HEMATOPOIESIS 74
7.5.1 GROWING DEMAND FOR STEM CELL THERAPY TO PROPEL GROWTH 74
TABLE 19 HUMANIZED MOUSE AND RAT MODEL MARKET FOR HEMATOPOIESIS, BY COUNTRY, 2020–2027 (USD MILLION) 74
7.6 TOXICOLOGY 75
7.6.1 RISING NUMBER OF CLINICAL STUDIES TO DRIVE DEMAND 75
TABLE 20 HUMANIZED MOUSE AND RAT MODEL MARKET FOR TOXICOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 76
7.7 OTHER APPLICATIONS 76
TABLE 21 HUMANIZED MOUSE AND RAT MODEL MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 77
8 HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER 78
8.1 INTRODUCTION 79
TABLE 22 HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 79
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 79
8.2.1 INCREASING R&D ON DRUG DEVELOPMENT TO DRIVE GROWTH 79
TABLE 23 HUMANIZED MOUSE AND RAT MODEL MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 81
8.3 CONTRACT RESEARCH ORGANIZATIONS 81
8.3.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE GROWTH 81
TABLE 24 HUMANIZED MOUSE AND RAT MODEL MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 82
8.4 ACADEMIC AND RESEARCH INSTITUTIONS 83
8.4.1 INCREASING LIFE SCIENCE R&D EXPENDITURE TO DRIVE GROWTH 83
TABLE 25 HUMANIZED MOUSE AND RAT MODEL MARKET FOR ACADEMIC AND RESEARCH INSTITUTIONS, BY COUNTRY, 2020–2027 (USD MILLION) 84
9 HUMANIZED MOUSE AND RAT MODEL MARKET, BY REGION 85
9.1 INTRODUCTION 86
TABLE 26 HUMANIZED MOUSE AND RAT MODEL MARKET, BY REGION, 2020–2027 (USD MILLION) 86
9.2 NORTH AMERICA 86
FIGURE 20 NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET SNAPSHOT 87
TABLE 27 NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
TABLE 28 NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 29 NORTH AMERICA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 30 NORTH AMERICA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 31 NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89
TABLE 32 NORTH AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 89
9.2.1 US 89
9.2.1.1 US to dominate North American market 89
TABLE 33 US: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 90
TABLE 34 US: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 90
TABLE 35 US: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 91
TABLE 36 US: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91
TABLE 37 US: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 91
9.2.2 CANADA 92
9.2.2.1 Government initiatives to drive market growth 92
TABLE 38 CANADA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 39 CANADA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 40 CANADA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 41 CANADA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 94
TABLE 42 CANADA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 94
9.3 EUROPE 95
TABLE 43 EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 44 EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 45 EUROPE: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 46 EUROPE: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 47 EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 96
TABLE 48 EUROPE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 97
9.3.1 GERMANY 97
9.3.1.1 Germany to account for largest share in European market 97
TABLE 49 GERMANY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 50 GERMANY: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 51 GERMANY: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 52 GERMANY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99
TABLE 53 GERMANY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 99
9.3.2 UK 99
9.3.2.1 Increasing cancer research to drive growth 99
TABLE 54 UK: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 55 UK: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 56 UK: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 57 UK: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101
TABLE 58 UK: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 101
9.3.3 FRANCE 101
9.3.3.1 Increasing government funding for research and investments in genomics to drive growth 101
TABLE 59 FRANCE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 60 FRANCE: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 61 FRANCE: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 62 FRANCE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 63 FRANCE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 103
9.3.4 ITALY 103
9.3.4.1 Increasing pharmaceutical production in Italy to drive growth 103
TABLE 64 ITALY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 65 ITALY: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104
TABLE 66 ITALY: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 67 ITALY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105
TABLE 68 ITALY: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 106
9.3.5 SPAIN 106
9.3.5.1 Rising R&D expenditure to boost growth 106
TABLE 69 SPAIN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 106
TABLE 70 SPAIN: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 71 SPAIN: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 72 SPAIN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
TABLE 73 SPAIN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 108
9.3.6 REST OF EUROPE 108
TABLE 74 ROE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 75 ROE: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 76 ROE: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109
TABLE 77 ROE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110
TABLE 78 ROE: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 110
9.4 ASIA PACIFIC 110
FIGURE 21 ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET SNAPSHOT 111
TABLE 79 ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 80 ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 81 ASIA PACIFIC: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 82 ASIA PACIFIC: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 83 ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 84 ASIA PACIFIC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 114
9.4.1 CHINA 114
9.4.1.1 China to dominate Asia Pacific market 114
TABLE 85 CHINA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 86 CHINA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 87 CHINA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 88 CHINA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 89 CHINA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 117
9.4.2 JAPAN 117
9.4.2.1 Growing research collaborations to drive market growth in Japan 117
TABLE 90 JAPAN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 91 JAPAN: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 92 JAPAN: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 93 JAPAN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
TABLE 94 JAPAN: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 119
9.4.3 INDIA 119
9.4.3.1 Growing biotech industry in India to drive market growth 119
TABLE 95 INDIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 96 INDIA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 97 INDIA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 98 INDIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 99 INDIA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 122
9.4.4 SOUTH KOREA 122
9.4.4.1 Growing efforts by government to drive market growth 122
TABLE 100 SOUTH KOREA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 101 SOUTH KOREA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 102 SOUTH KOREA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 103 SOUTH KOREA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 104 SOUTH KOREA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 124
9.4.5 REST OF ASIA PACIFIC 124
TABLE 105 ROAPAC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 106 ROAPAC: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 107 ROAPAC: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 108 ROAPAC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126
TABLE 109 ROAPAC: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 127
9.5 LATIN AMERICA 127
9.5.1 INCREASING PHARMACEUTICAL R&D EXPENDITURE TO DRIVE MARKET GROWTH 127
TABLE 110 LATIN AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 111 LATIN AMERICA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 112 LATIN AMERICA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 113 LATIN AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 129
TABLE 114 LATIN AMERICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 129
9.6 MIDDLE EAST & AFRICA 130
9.6.1 UAE HAS EMERGED AS KEY MARKET IN MEA REGION 130
TABLE 115 MIDDLE EAST & AFRICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY TYPE, 2020–2027 (USD MILLION) 130
TABLE 116 MIDDLE EAST & AFRICA: HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 117 MIDDLE EAST & AFRICA: CELL-BASED HUMANIZED MOUSE MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 118 MIDDLE EAST & AFRICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 119 MIDDLE EAST & AFRICA: HUMANIZED MOUSE AND RAT MODEL MARKET, BY END USER, 2020–2027 (USD MILLION) 132
10 COMPETITIVE LANDSCAPE 133
10.1 OVERVIEW 133
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 133
FIGURE 22 KEY DEVELOPMENTS IN HUMANIZED MOUSE AND RAT MODEL MARKET, 2019–2022 133
10.3 MARKET SHARE ANALYSIS 134
FIGURE 23 HUMANIZED MOUSE AND RAT MODEL MARKET SHARE, BY KEY PLAYER, 2021 134
TABLE 120 HUMANIZED MOUSE AND RAT MODEL MARKET: DEGREE OF COMPETITION 134
10.4 COMPANY EVALUATION MATRIX 135
10.4.1 STARS 135
10.4.2 EMERGING LEADERS 135
10.4.3 PERVASIVE PLAYERS 136
10.4.4 PARTICIPANTS 136
FIGURE 24 HUMANIZED MOUSE AND RAT MODEL MARKET: COMPANY EVALUATION MATRIX, 2021 136
10.5 COMPANY EVALUATION MATRIX: START-UPS/SMES 137
10.5.1 PROGRESSIVE COMPANIES 137
10.5.2 STARTING BLOCKS 137
10.5.3 RESPONSIVE COMPANIES 137
10.5.4 DYNAMIC COMPANIES 137
FIGURE 25 HUMANIZED MOUSE AND RAT MODEL MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2021 138
10.6 FOOTPRINT ANALYSIS OF COMPANIES 139
10.6.1 PRODUCT FOOTPRINT OF COMPANIES 139
TABLE 121 PRODUCT FOOTPRINT OF COMPANIES: HUMANIZED MOUSE AND RAT MODEL MARKET (2021) 139
10.6.2 END-USER FOOTPRINT OF COMPANIES 140
TABLE 122 END-USER FOOTPRINT OF COMPANIES: HUMANIZED MOUSE AND RAT MODEL MARKET (2021) 140
10.6.3 REGIONAL FOOTPRINT OF COMPANIES 141
TABLE 123 REGIONAL FOOTPRINT OF COMPANIES: HUMANIZED MOUSE AND RAT MODEL MARKET (2021) 141
10.7 COMPETITIVE SCENARIO 141
TABLE 124 PRODUCT LAUNCHES 141
TABLE 125 DEALS 142
11 COMPANY PROFILES 143
11.1 KEY PLAYERS 143
(Business Overview, Products offered, Recent Developments, MnM View)*
11.1.1 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 143
TABLE 126 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW 143
FIGURE 26 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021) 144
11.1.2 THE JACKSON LABORATORY 147
TABLE 127 THE JACKSON LABORATORY: BUSINESS OVERVIEW 147
FIGURE 27 THE JACKSON LABORATORY: COMPANY SNAPSHOT (2021) 147
11.1.3 TACONIC BIOSCIENCES, INC. 150
TABLE 128 TACONIC BIOSCIENCES, INC.: BUSINESS OVERVIEW 150
11.1.4 CROWN BIOSCIENCE 152
TABLE 129 CROWN BIOSCIENCE: BUSINESS OVERVIEW 152
11.1.5 CHAMPIONS ONCOLOGY, INC. 154
TABLE 130 CHAMPIONS ONCOLOGY: BUSINESS OVERVIEW 154
FIGURE 28 CHAMPIONS ONCOLOGY: COMPANY SNAPSHOT (2022) 154
11.1.6 INOTIV 156
TABLE 131 INOTIV: BUSINESS OVERVIEW 156
FIGURE 29 INOTIV: COMPANY SNAPSHOT 157
11.1.7 HERA BIOLABS 160
TABLE 132 HERA BIOLABS: BUSINESS OVERVIEW 160
11.1.8 GENOWAY 161
TABLE 133 GENOWAY: BUSINESS OVERVIEW 161
11.1.9 BEIJING VITALSTAR BIOTECHNOLOGY CO. LTD. 162
TABLE 134 VITALSTAR BIOTECHNOLOGY: BUSINESS OVERVIEW 162
11.1.10 INGENIOUS TARGETING LABORATORY 163
TABLE 135 INGENIOUS TARGETING LABORATORY: BUSINESS OVERVIEW 163
11.1.11 AXENIS 164
TABLE 136 AXENIS: BUSINESS OVERVIEW 164
11.1.12 TRANS GENIC 165
TABLE 137 TRANS GENIC: BUSINESS OVERVIEW 165
11.1.13 HARBOUR ANTIBODIES (A SUBSIDIARY OF HARBOUR BIOMED) 166
TABLE 138 HARBOUR ANTIBODIES: BUSINESS OVERVIEW 166
11.1.14 ONCODESIGN 167
TABLE 139 ONCODESIGN: BUSINESS OVERVIEW 167
11.1.15 PHARMATEST SERVICES 168
TABLE 140 PHARMATEST SERVICES: BUSINESS OVERVIEW 168
*Details on Business Overview, Products offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 169
11.2.1 OZGENE PTY LTD. 169
11.2.2 TRANSCURE BIOSERVICES 169
11.2.3 CYAGEN BIOSCIENCES 170
11.2.4 GVK BIO 170
11.2.5 BIOCYTOGEN 171
12 APPENDIX 172
12.1 DISCUSSION GUIDE 172
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 175
12.3 CUSTOMIZATION OPTIONS 177
12.4 RELATED REPORTS 177
12.5 AUTHOR DETAILS 178

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒト化マウス＆ラットモデルの世界市場予測（～2027）：種類別、用途別、エンドユーザー別、地域別(Humanized Mouse and Rat Model Market by Type (Genetic, Cell-Based (CD34, PBMC, BLT)), Application (Neuroscience, Oncology, Toxicology, Immunology & Infectious diseases, Hematopoiesis), End Users, and Region - Global Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒト化マウス＆ラットモデルの世界市場予測（～2027）：種類別、用途別、エンドユーザー別、地域別

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp